- 全部删除
您的购物车当前为空
BMS309403 是有效的、选择性脂肪细胞脂肪酸结合蛋白 aFABP 抑制剂。它可改善载脂蛋白 E 缺乏症小鼠和培养的人内皮细胞的内皮功能。它能够与蛋白质内部的脂肪酸结合口袋相互作用,竞争性地抑制内源性脂肪酸的结合。

BMS309403 是有效的、选择性脂肪细胞脂肪酸结合蛋白 aFABP 抑制剂。它可改善载脂蛋白 E 缺乏症小鼠和培养的人内皮细胞的内皮功能。它能够与蛋白质内部的脂肪酸结合口袋相互作用,竞争性地抑制内源性脂肪酸的结合。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 236 | In stock | |
| 5 mg | ¥ 537 | In stock | |
| 10 mg | ¥ 940 | In stock | |
| 25 mg | ¥ 2,050 | In stock | |
| 50 mg | ¥ 2,890 | In stock | |
| 100 mg | ¥ 4,050 | 5日内发货 | |
| 200 mg | ¥ 5,770 | 5日内发货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 537 | In stock |
BMS-309403 相关产品
| 产品描述 | BMS309403 is a potent and selective inhibitor of adipocyte fatty acid binding protein aFABP. It improves endothelial function in apolipoprotein E-deficient mice and cultured human endothelial cells. It interacts with the fatty acid binding pocket inside the protein and competitively inhibits the binding of endogenous fatty acids. |
| 靶点活性 | FABP4:< 2 nM, FABP5: 350 nM , FABP3: 250 nM |
| 体外活性 | 用BMS309403治疗以剂量和时间依赖性方式显着降低 THP-1 巨噬细胞的 MCP-1 产量 。[1] |
| 体内活性 | 方法:糖尿病发病3周后,小鼠口服BMS309403(40mg / kg ,每天)治疗3周。在治疗期间,监测血糖水平。 |
| 分子量 | 474.55 |
| 分子式 | C31H26N2O3 |
| CAS No. | 300657-03-8 |
| Smiles | CCc1c(c(nn1-c1ccccc1-c1cccc(OCC(O)=O)c1)-c1ccccc1)-c1ccccc1 |
| 密度 | 1.17 g/cm3 |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 20 mM, Heating is recommended. DMSO: 50 mg/mL (105.36 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容